Newsroom

MCLEAN, Va.--(BUSINESS WIRE)--Toshiba and the National Science Teaching Association (NSTA) today announce eight national winners of the 34th annual Toshiba/NSTA ExploraVision competition, the world’s largest K-12 science competition. This year’s winners have shared innovative proposals to help overcome some of the greatest challenges facing the world today, from healthcare challenges to transportation efforts to protecting the environment. The Toshiba/NSTA ExploraVision competition is designed...

PHILADELPHIA & SAN FRANCISCO--(BUSINESS WIRE)--Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced the presentation of new preclinical data supporting its SEND (Synthetic Efficacy eNableD) T cell armoring strategy at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting, taking place May 11–15, 2026, in Boston. The data will be presented in a poster entitled, “SEND – A T cell ar...

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report first quarter 2026 financial results on Monday, May 4, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. The webcast and dial-in information can be accessed on the Investor page of Travere’s website at https://ir.travere.com/events-and-presentations. Foll...

PHOENIX--(BUSINESS WIRE)--SmartRent today announced the launch of its strategic value-added reseller program to serve small and mid-market multifamily owners and operators....

NEW YORK--(BUSINESS WIRE)--Rithm Capital Corp. (NYSE: RITM) ("Rithm"), a global alternative asset manager, today announced that its commercial real estate platform Paramount Group, has officially rebranded as Elecor Properties ("Elecor"), a premier real estate platform redefining the modern workplace. The new identity reflects a strategic transformation from a high quality, Class A office portfolio into an operating platform built for the next evolution of the workplace. Elecor Properties is pu...

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics to present new capsids and AI advancements in gene delivery at the 29th American Society of Gene & Cell Therapy Annual Meeting...

BOSTON--(BUSINESS WIRE)--Strand Therapeutics to present preclinical data on its programmable mRNA in vivo CAR-T platform at the ASGCT 2026 Annual Meeting...

LONDON & NEW YORK--(BUSINESS WIRE)--AviadoBio Ltd. (“AviadoBio”) and Apertura Gene Therapy (“Apertura”), a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced a licensing agreement for Apertura’s TfR1 CapX™, a novel, intravenously-delivered AAV capsid designed to target human transferrin receptor 1 (hTfR1), cross the blood-brain barrier, and enable broad distribution to the brain and spinal cord. Under the agreement, AviadoBio will leve...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sail to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA™ CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026...

OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Financial Inc. (NYSE: EFC) ("we") today announced an estimated book value per share of common stock of $13.56 as of March 31, 2026. This estimate includes the effect of the previously announced monthly dividend of $0.13 per share of common stock, to be paid on April 30, 2026 to holders of record on March 31, 2026, with the same ex-dividend date. Cautionary Statement Regarding Forward-Looking Statements Estimated book value per common share is sub...